Results 191 to 200 of about 5,003 (295)

HLA alloimmunization and blood requirements in orthotopic liver transplantation. [PDF]

, 1989
Duquesnoy, R, Esquivel, CO, Kang, YG, Marino, IR, Starzl, TE, Weber, T   +5 more
core  

Impact of platelet transfusion refractoriness in the first 30 days post-hematopoietic stem cell transplantation on outcomes of patients with myelodysplastic syndrome. [PDF]

Front Immunol
Zhang Y, Wang Y, Ma R, Liu L, Sun J, Chen X, Yang D, Pang A, Zhang R, Ma Q, Zhai W, He Y, Wei J, Zhang T, Jiang E, Han M, Feng S.   +16 more
europepmc   +1 more source

Alloantibody Levels, Immunoglobulin Degradation Products, and Platelet Transfusion Response over Successful Desensitization of Severe Alloimmune Platelet Refractoriness with a Novel IgG-Targeted Enzyme Therapeutic

, 2023
Adnan Qamar, Sofia Järnum, Annika Sundberg, Laurie Pearson, Eva Guan, John J. Xin, Andreas K. Klein, Jensyn Cone Sullivan   +7 more
openalex   +1 more source

HLA‐matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening [PDF]

, 2019
Aukje L. Kreuger, Anja BU Mäkelburg, Judith A.E. Somers, Bert Tomson, Leo M.G. van de Watering, Johanna G. van der Bom, Marian G.J. van Kraaij, Claudia M Weller   +7 more
openalex   +1 more source

Development of a Calculated Panel Reactive Antibody Web Service with Local Frequencies for Platelet Transfusion Refractoriness Risk Stratification. [PDF]

J Pathol Inform, 2019
Gordon WJ, Ainsworth L, Aronson S, Baronas J, Kaufman RM, Guleria I, Milford EL, Oates M, Paz RD, Yeung MY, Lane WJ.   +10 more
europepmc   +1 more source

Prestorage leukocyte depletion is not necessarily required for the prevention of refractoriness to platelet transfusion [letter; comment] [PDF]

, 1995
J de Wolf, A Westerterp, C Smit Sibinga, MR Halie   +3 more
openalex   +3 more sources

Movement of Anti-HLA antibody titer by m-PSL pulse therapy in three patients with platelet transfusion refractoriness.

, 1990
Hiroyuki Kambayashi, Shin Matsuda, Hiroyasu Yasuda, Hitoshi Ohto   +3 more
openalex   +2 more sources

Blood type antigen and genetic analysis.2.Blood platelets.Molecular biological study on isoantigen Sib (HPA2) concerning platelet transfusion refractory disease is described.

, 1994
Mitsuru Murata
openalex   +2 more sources

Can we “terminate” alloimmune platelet transfusion refractoriness? [PDF]

Transfusion, 2016
Ralph R. Vassallo, Philip J. Norris
openaire   +3 more sources

Predictive Factors for Adverse Outcomes After Use of Donor Cell Infusion (DCI) in Patients with Relapsed Hematological Malignancies Treated with Allogeneic Hematopoietic Cell Transplantation (alloHCT) [PDF]

, 2012
Abounader, D., Andresen, S., Bejanyan, N., Bolwell, B., Copelan, E., Dean, R., Duong, H., Kalaycio, M., Pohlman, B., Rybicki, L., Sobecks, R.   +10 more
core   +1 more source